Athanor Capital, LP Molecular Templates, Inc. Transaction History

Athanor Capital, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$8.48 - $12.23 $151,537 - $218,550	-17,870 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$9.99 - $14.41 $176,723 - $254,912	-17,690 Reduced 49.75%	17,870 $195,000
Q2 2020 Aug 13, 2020	BUY	$12.28 - $17.63 $436,676 - $626,922	35,560 New	35,560 $490,000
Q1 2020 May 14, 2020	SELL	$11.31 - $18.26 $237,577 - $383,569	-21,006 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$6.44 - $14.21 $135,278 - $298,495	21,006 New	21,006 $294,000
Q3 2019 Nov 14, 2019	SELL	$4.6 - $8.46 $92,920 - $170,892	-20,200 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$5.83 - $8.42 $117,766 - $170,084	20,200 New	20,200 $169,000

499K

Ticker MTEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,351,600
Market Cap $7.33M
Description
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developi...

Get notified when there are updates to the investment portfolio of Athanor Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Athanor Capital, LP with notifications on news.